R. Whittaker

Effect of G Protein‐Coupled Receptor Kinase 2 on the Sensitivity of M4 Muscarinic Acetylcholine Receptors to Agonist‐Induced Internalization and Desensitization in NG108‐15 Cells

P. Szekeres, J. Edwardson, E. Holroyd, 1999, Journal of neurochemistry.

A new series of neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase.

James S. Scott, B. Barlaam, R. Ducray, 2008, Bioorganic & medicinal chemistry letters.

Neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase.

James S. Scott, B. Barlaam, R. Bradbury, 2007, Bioorganic & Medicinal Chemistry Letters.

Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530

N. Carragher, P. Elvin, B. Davies, 2009, Molecular oncology.

Biomarkers in oncology drug development

D. Hodgson, G. Clack, A. Herath, 2009, Molecular oncology.

361 Preclinical activity of AZD0530, a novel, oral, potent and selective inhibitor of the Src family kinases

P. Plé, J. Curwen, V. Jacobs, 2004 .